-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V7WDyrd1k289nnNIaNCU7MaRmsVE6JshcYYubpvsM9Y7cCYD3ZAI2pfU71aeOQFs iGtXwJdNHzZJa01md5dxpw== 0001127602-09-024547.txt : 20091208 0001127602-09-024547.hdr.sgml : 20091208 20091208143041 ACCESSION NUMBER: 0001127602-09-024547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091204 FILED AS OF DATE: 20091208 DATE AS OF CHANGE: 20091208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GODDARD COLIN CENTRAL INDEX KEY: 0001225199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 091228384 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2009-12-04 0000729922 OSI PHARMACEUTICALS INC OSIP 0001225199 GODDARD COLIN C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD MELVILLE NY 11747 1 1 Chief Executive Officer Common Stock 2009-12-04 4 A 0 200 33.68 A 130288 D Common Stock 2009-12-04 4 F 0 75 33.68 D 130213 D Represents a gift of Common Stock of the Company given to all employees upon completion of 20 years of service with the Company. Reflects the withholding of shares by the Company to satisfy the tax liability for the shares given to Dr. Goddard for his service award. Exhibit List: Exhibit 24--Power of Attorney /s/ Pierre Legault, attorney-in-fact for Dr. Goddard 2009-12-08 -----END PRIVACY-ENHANCED MESSAGE-----